4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000101
Chief Financial Officer sold 1,597 shares at $28.36 ($45,291)
- Chief Financial Officer acquired 5,380 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Jones Cecilia · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-28 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,380 | 5,380 | D | ||
| 2023-06-30 | Sale : show line 2 in the form 10b5-1 | −1,597 | $28.36 | $45,291 | 3,783 | D |
| Open-market sales · 1,597 sh · avg $28.36 · $45,291 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-06-28 | Exercise or conversion : show line 3 in the form 10b5-1 Performance share units | −5,380 | 5,380 | D |
Loading xslF345X04/wk-form4_1688155416.xml…